Long-lasting effects of sublingual immunotherapy according to its duration: A 15-year prospective study

Journal of Allergy and Clinical Immunology

Volumn 126, Issue 5, 2010, Pages 969-975

  Marogna, Maurizio ^a   Spadolini, Igino ^b   Massolo, Alessandro ^c   Canonica, Giorgio Walter ^d   Passalacqua, Giovanni ^d  

^a OSPEDALE DI CIRCOLO   (Italy)

^b Medical Department   (Italy)

^c UNIVERSITY OF CALGARY   (Canada)

^d Padiglione Maragliano ^*  (Italy)

Author keywords

Allergic rhinitis; House dust mite; Long lasting effect; Sublingual immunotherapy

Indexed keywords

BECLOMETASONE; BUDESONIDE; CETIRIZINE; CROMOGLYCATE DISODIUM; FLUTICASONE; HOUSE DUST ALLERGEN; SALBUTAMOL; SALMETEROL;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; NOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN SENSITIZATION; SUBLINGUAL IMMUNOTHERAPY; TREATMENT DURATION; VACCINATION; WINTER;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; EOSINOPHILS; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL MUCOSA; PYROGLYPHIDAE; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, PERENNIAL; TIME; YOUNG ADULT;

EID: 78049463603     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.08.030     Document Type: Article

References (27)

1. Bousquet J, Lockey RF, Malling HJ, editors. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;54(suppl 82):1-33.
2. Canonica GW, editor. World Allergy Organization position paper on sublingual immunotherapy. Allergy 2009;64(suppl 91):1-59.
3. A.J. Frew Allergen immunotherapy J Allergy Clin Immunol 125 suppl 2 2010 S306 S313
4. Bousquet J, Van Cauwenberge P, editors. Allergic Rhinitis and Its Impact on Asthma. J Allergy Clin Immunol 2001;108(suppl):S146-S150.
5. L.K. James, and S.R. Durham Update on mechanisms of allergen injection immunotherapy Clin Exp Allergy 38 2008 1074 1088
6. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
7. L. Jacobsen, B. Niggemann, S. Dreborg, H.A. Ferdousi, S. Halken, and A. Høst Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study Allergy 62 2007 943 948
8. P.A. Eng, M. Borer-Reinhold, I.A. Heijnen, and H.P. Gnehm Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood Allergy 61 2006 198 201
9. V. Di Rienzo, F. Marcucci, P. Puccinelli, S. Parmiani, F. Frati, and L. Sensi Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study Clin Exp Allergy 33 2003 206 210
10. R. Tahamiler, G. Saritzali, and S. Canakcioglu Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis Laryngoscope 117 2007 965 969
11. S. Dreborg, and A. Frew Position paper: allergen standardization and skin tests Allergy 48 suppl 14 1983 49 82
12. Global Initiative for the Management of Asthma (GINA) 1995 National Heart, Lung, and Blood Institute Bethesda
13. P.J. Sterk, L.M. Fabbri, P.H. Quanjer, D.W. Cockcroft, P.M. O'Byrne, and S.D. Anderson Airway responsiveness standardized challenge testing with pharmacological, physical and sensitising stimuli in adults. Report of the Working Party on Standardization of Lung Function Tests, European Coal and Steel Community. Official Statement of the European Respiratory Society Eur Respir J 16 suppl 1993 53 83
14. K. Scadding, and J. Brostoff Low dose sublingual therapy in patients with allergic rhinitis due to dust mite Clin Allergy 16 1986 483 491
15. G.W. Scadding, M.H. Shamji, M.R. Jacobson, D.I. Lee, D. Wilson, and M.T. Lima Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells Clin Exp Allergy 40 2010 598 606
16. L. Cosmi, V. Santarlasci, R. Angeli, F. Liotta, L. Maggi, and F. Frosali Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production Clin Exp Allergy 36 2006 261 272
17. J. Savolainen, L. Jacobsen, and E. Valovirta Sublingual immunotherapy in children modulates allergen induced in vitro expression of cytokine mRNA in PBMC Allergy 61 2006 1184 1190
18. A.O. Eifan, T. Akkoc, A. Yildiz, S. Keles, C. Ozdemir, and N.N. Bahceciler Clinical efficacy and immunological mechanisms of sublingual and subcutaneous Immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial Clin Exp Allergy 40 2010 922 932
19. S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. de Monchy, and S. Rak Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet J Allergy Clin Immunol 125 2010 131 138 e1-7
20. H. Ott, J. Sieber, R. Brehler, R. Fölster-Holst, A. Kapp, and L. Klimek Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study Allergy 64 2009 1394 1401
21. G. Pajno, G. Passalacqua, D. Vita, V. Caminiti, and G. Barberio Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial Allergy 59 2004 883 887
22. M. Marogna, I. Spadolini, A. Massolo, G.W. Canonica, and G. Passalacqua Clinical functional and immunological effects of sublingual immunotherapy in birch allergy J Allergy Clin Immunol 115 2005 1184 1188
23. M. Marogna, I. Spadolini, A. Massolo, D. Berra, P. Zanon, and E. Chiodini Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen Ann Allergy Asthma Immunol 102 2009 69 75
24. J.L. Brozek, C. Baena Cagnani, S. Bonini, G.W. Canonica, G. Rasi, and R.G. van Wijk Methodology for development of the Allergic Rhinitis and Its Impact on Asthma guidelines - 2008 update Allergy 63 2008 38 46
25. T.B. Casale, G.W. Canonica, J. Bousquet, L. Cox, R. Lockey, and H.S. Nelson Recommendations for appropriate sublingual immunotherapy clinical trials J Allergy Clin Immunol 124 2009 665 670
26. A. Hrobjartsson, and P.C. Gotzsche Is the placebo powerless. An analysis of clinical trials comparing placebo with no treatment N Engl J Med 344 2001 1594 1602
27. G.W. Canonica, C. Baena Cagnani, J. Bousquet, P.J. Bousquet, G. Passalacqua, and P. Potter Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce Allergy 62 2007 317 324